We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Spatial Transcriptomics Technique Enables Visualization of Gene Expression in Tissues

By LabMedica International staff writers
Posted on 12 Jul 2016
A team of Swedish researchers has developed a high-resolution method for resolving the transcriptome – the library of active genes and RNAs – in histological samples of patients' tissues.

Analysis of the pattern of proteins or messenger RNAs (mRNAs) in histological tissue sections is a vital aspect of biomedical research and diagnostics. More...
Due to the complexities of current techniques, this typically involves the visualization of only a few proteins or expressed genes at a time.

Investigators at the Karolinska Institutet (Stockholm, Sweden) and the Royal Institute of Technology (Stockholm, Sweden) described a method for visualization and quantitative analysis of the complete transcriptome with spatial resolution in individual tissue sections.

The method, which they called "spatial transcriptomics", relied on positioning histological sections onto arrayed reverse transcription primers with unique positional barcodes. Reverse transcription was followed by sequencing and computational reconstruction, and this could be done for multiple genes simultaneously. By positioning histological sections on arrayed reverse transcription primers with unique positional barcodes, the investigators demonstrated high-quality RNA-sequencing data with maintained two-dimensional positional information from mouse brain and human breast cancer.

"By placing tissue sections on a glass slide on which we have placed DNA strands with built in address labels we have been able to label the RNA molecules formed by active genes," said senior author Dr. Jonas Frisén, professor of stem cell research at the Karolinska Institutet. "When we analyze the presence of RNA molecules in the sample, the address labels show where in the section the molecules were and we can get high-resolution information on where different genes are active. It makes it possible to study which genes are active in tissues with greater resolution and precision than ever before, which is valuable to both basic research and diagnostics."

The method was described in detail in a paper published in the July 1, 2016, issue of the journal Science.

Related Links:
Karolinska Institutet
Royal Institute of Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.